Reviva Pharmaceuticals Warrants
RVPHW
RVPHW was delisted on the 12th of December, 2025.
2 hedge funds and large institutions have $12.8K invested in Reviva Pharmaceuticals Warrants in 2025 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, reducing their positions, and 2 closing their positions.
2,491% more capital invested
Capital invested by funds: $493 → $12.8K (+$12.3K)
2.22% more ownership
Funds ownership: 0.03% → 2.25% (+2.2%)
33% less funds holding
Funds holding: 3 → 2 (-1)
50% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$5.33K |
| 2 |
VF
Virtu Financial
New York
|
+$909 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Toronto Dominion Bank
Toronto, Ontario,
Ontario, Canada
|
-$3 |
| 2 |
CS
Clear Street
New York
|
-$1 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $10.8K | +$5.33K | +119,467 | +786% |
|
|
VF
2
Virtu Financial
New York
| $2K | +$909 | +20,383 | New |
|
|
3
Toronto Dominion Bank
Toronto, Ontario,
Ontario, Canada
| – | -$3 | -100 | Closed |
|
|
CS
4
Clear Street
New York
| – | -$1 | -22 | Closed |
|
RVPHW Hedge Fund Activity: Q3 2025 in Review
2 of the 7,620 institutional investors tracked by Wall St. Rank reported a position in Reviva Pharmaceuticals Warrants (RVPHW) for Q3 2025, worth a combined $12.8K — up 2,491% from $493 a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of RVPHW and 1 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 1 added.
The largest buyer was Susquehanna International Group, adding an estimated $5.33K. The largest seller was Toronto Dominion Bank, exiting entirely with an estimated $3 sold.
- 2 institutional investors held Reviva Pharmaceuticals Warrants (RVPHW) as of Q3 2025, down from 3 in Q2 2025.
- Funds reported $12.8K of Reviva Pharmaceuticals Warrants stock for Q3 2025, up 2,491% quarter-over-quarter.
- 1 fund opened new Reviva Pharmaceuticals Warrants positions in Q3 2025 and 2 closed out, a net change of -1 holder.
- The largest Reviva Pharmaceuticals Warrants buyer in Q3 2025 was Susquehanna International Group, an estimated $5.33K added.
- The largest Reviva Pharmaceuticals Warrants seller in Q3 2025 was Toronto Dominion Bank, an estimated $3 sold.
Based on aggregated 13F filings for Q3 2025.